Associated Papers
Combinatorial batching of DNA for ultralow-cost detection of pathogenic variants.
Stoltze UK et al.
Genome Medicine, 2023
36918911 (PubMed )
Supplement: 13073_2023_1167_MOESM2_ESM.xlsx › Table_S4_LoFP_variants
Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination.
Setton J et al.
Npj Breast Cancer, 2021
Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2).
Swisher EM et al.
Nature Communications, 2021
33941784 (PubMed )
Supplement: 41467_2021_22582_MOESM1_ESM.pdf
Analysis of 11 candidate genes in 849 adult patients with suspected hereditary cancer predisposition.
Cavaillé M et al.
Genes, Chromosomes & Cancer, 2021
Germline variants in cancer genes in high-risk non-BRCA patients from Puerto Rico.
Dutil J et al.
Scientific Reports, 2019
Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs.
Li N et al.
Breast Cancer Research : Bcr, 2018
Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancers.
Golmard L et al.
European Journal of Human Genetics : Ejhg, 2017
Patterns and functional implications of rare germline variants across 12 cancer types.
Lu C et al.
Nature Communications, 2015
26689913 (PubMed )
Supplement: ncomms10086-s3.xlsx › supplementary_data_2
Germline RAD51B truncating mutation in a family with cutaneous melanoma.
Wadt KA et al.
Familial Cancer, 2015
Select a paper to view details